Literature DB >> 24698487

Staging laparoscopy in pancreatic cancer: a potential role for advanced laparoscopic techniques.

Thomas Schnelldorfer1, Andrew I Gagnon2, Richard T Birkett2, Gail Reynolds3, Kristen M Murphy4, Roger L Jenkins5.   

Abstract

BACKGROUND: The role of staging laparoscopy in pancreatic cancer in the age of high-resolution CT scans is under debate. This study's aim is to evaluate the efficacy of staging laparoscopy in this disease. STUDY
DESIGN: A retrospective cohort study was conducted evaluating patients who underwent operative treatment for radiographic stage I to III pancreatic cancer between July 2003 and October 2012. Radiographic follow-up was 94% at 6 months.
RESULTS: Of 274 patients who met inclusion criteria, 136 underwent staging laparoscopy, which identified radiographic occult distant metastases in 2% (3 of 136). However, subsequent laparotomy identified an additional 9% (12 of 136) harboring distant metastases in regions not visualized on standard staging laparoscopy; specifically, the posterior liver surface, paraduodenal retroperitoneum, proximal jejunal mesentery, and lesser sac. The remaining 138 patients underwent initial staging laparotomy, which showed similar results identifying radiographic occult distant disease in 11% (15 of 138). Within 6 months after the operation, peritoneal or subcapsular liver metastases developed in an additional 6% (15 of 257)-disease that potentially could have been diagnosed at the time of operation-providing a false-negative rate of 88% for staging laparoscopy compared with 36% for staging laparotomy.
CONCLUSIONS: Despite the availability of high-resolution CT scans, occult distant metastases can still be found in 11% of patients during the operation. In the absence of reliable risk factors to predict distant metastases, staging laparoscopy should be offered to all patients with radiographic localized disease. However, the results favor extended laparoscopic staging with evaluation of the posterior liver surface, mobilization of the duodenum, evaluation of the proximal jejunal mesentery, and visualization of the lesser sac.
Copyright © 2014 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24698487     DOI: 10.1016/j.jamcollsurg.2014.02.018

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  9 in total

1.  Diagnostic Laparoscopy Prior to Neoadjuvant Therapy in Pancreatic Cancer Is High Yield: an Analysis of Outcomes and Costs.

Authors:  June S Peng; Jeffrey Mino; Rosebel Monteiro; Gareth Morris-Stiff; Noaman S Ali; Jane Wey; Kevin M El-Hayek; R Matthew Walsh; Sricharan Chalikonda
Journal:  J Gastrointest Surg       Date:  2017-06-08       Impact factor: 3.452

2.  Diagnostic Laparoscopy in Patients With Peritoneal Carcinomatosis Is Safe and Does Not Delay Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy.

Authors:  David N Hanna; Muhammad O Ghani; Andrew Hermina; Alexander Mina; Christina E Bailey; Kamran Idrees; Deepa Magge
Journal:  Am Surg       Date:  2021-11-03       Impact factor: 0.688

Review 3.  Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.

Authors:  Victoria B Allen; Kurinchi Selvan Gurusamy; Yemisi Takwoingi; Amun Kalia; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2016-07-06

4.  Tumor-specific near-infrared nanobody probe rapidly labels tumors in an orthotopic mouse model of pancreatic cancer.

Authors:  Thinzar M Lwin; Sophie Hernot; Hannah Hollandsworth; Siamak Amirfakhri; Filemoni Filemoni; Pieterjan Debie; Robert M Hoffman; Michael Bouvet
Journal:  Surgery       Date:  2020-05-04       Impact factor: 3.982

5.  A nomogram of preoperative predictors for occult metastasis in patients with PDAC during laparoscopic exploration.

Authors:  Jiachen Ge; Lei Li; Zhaolai Ma; Bin Jiang; Chunhui Yuan; Hangyan Wang; Ying Peng; Dianrong Xiu
Journal:  Gland Surg       Date:  2021-01

6.  Korean Surgical Practice Guideline for Pancreatic Cancer 2022: A summary of evidence-based surgical approaches

Authors:  Seung Eun Lee; Sung-Sik Han; Chang Moo Kang; Wooil Kwon; Kwang Yeol Paik; Ki Byung Song; Jae Do Yang; Jun Chul Chung; Chi-Young Jeong; Sun-Whe Kim
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2022-02-28

Review 7.  Role of laparoscopy in hepatobiliary malignancies.

Authors:  Prabhu Arumugam; Vickna Balarajah; Jennifer Watt; Ajit T Abraham; Satyajit Bhattacharya; Hemant M Kocher
Journal:  Indian J Med Res       Date:  2016-04       Impact factor: 2.375

8.  Photodynamic diagnosis of peritoneal metastasis in human pancreatic cancer using 5-aminolevulinic acid during staging laparoscopy.

Authors:  Kyoichi Harada; Yasutoshi Murayama; Hidemasa Kubo; Hisataka Matsuo; Ryo Morimura; Hisashi Ikoma; Hitoshi Fujiwara; Kazuma Okamoto; Tohru Tanaka; Eigo Otsuji
Journal:  Oncol Lett       Date:  2018-05-17       Impact factor: 2.967

9.  Fluorescent humanized anti-CEA antibody specifically labels metastatic pancreatic cancer in a patient-derived orthotopic xenograft (PDOX) mouse model.

Authors:  Thinzar M Lwin; Kentaro Miyake; Takashi Murakami; Jonathan C DeLong; Siamak Amirfakhri; Filemoni Filemoni; Sang Nam Yoon; Paul J Yazaki; John E Shivley; Brian Datnow; Bryan M Clary; Robert M Hoffman; Michael Bouvet
Journal:  Oncotarget       Date:  2018-12-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.